Abstract:Increasing evidence suggests that the chronicity of wounds is associated with the presence of bacterial biofilms. Therefore, novel wound care products are being developed, which can inhibit biofilm formation and/or treat already formed biofilms. A lack of standardized assays for the analysis of such novel antibacterial drug delivery systems enhances the need for appropriate tools and models for their characterization. Herein, we demonstrate that optimized and biorelevant in vitro and ex vivo wound infection and biofilm models offer a convenient approach for the testing of novel antibacterial wound dressings for their antibacterial and antibiofilm properties, allowing one to obtain qualitative and quantitative results. The in vitro model was developed using an electrospun (ES) thermally crosslinked gelatin-glucose (GEL-Glu) matrix and an ex vivo wound infection model using pig ear skin. Wound pathogens were used for colonization and biofilm development on the GEL-Glu matrix or pig skin with superficial burn wounds. The in vitro model allowed us to obtain more reproducible results compared with the ex vivo model, whereas the ex vivo model had the advantage that several pathogens preferred to form a biofilm on pig skin compared with the GEL-Glu matrix. The in vitro model functioned poorly for Staphylococcus epidermidis biofilm formation, but it worked well for Escherichia coli and Staphylococcus aureus, which were able to use the GEL-Glu matrix as a nutrient source and not only as a surface for biofilm growth. On the other hand, all tested pathogens were equally able to produce a biofilm on the surface of pig skin. The developed biofilm models enabled us to compare different ES dressings [pristine and chloramphenicol-loaded polycaprolactone (PCL) and PCL-poly(ethylene oxide) (PEO) (PCL/PEO) dressings] and understand their biofilm inhibition and treatment properties on various pathogens. Furthermore, we show that biofilms were formed on the wound surface as well as on a wound dressing, indicating that the demonstrated methods mimic well the in vivo situation. Colony forming unit (CFU) counting and live biofilm matrix as well as bacterial DNA staining together with microscopic imaging were performed for biofilm quantification and visualization, respectively. The results showed that both wound biofilm models (in vitro and ex vivo) enabled the evaluation of the desired antibiofilm properties, thus facilitating the design and development of more effective wound care products and screening of various formulations and active substances.

Biofilm detection by wound blotting can predict slough development in pressure ulcers: A prospective observational study

Assessing Biofilm at the Bedside: Exploring Reliable Accessible Biofilm Detection Methods

Effectiveness of biofilm‐based wound care system on wound healing in chronic wounds

Rapid detection of biofilm with modified alcian blue staining: In‐vitro protocol improvement and validation with clinical cases

Prototype Development of the Intelligent Hydrogel Wound Dressing and Its Efficacy in the Detection of Model Pathogenic Wound Biofilms

A Diagnostic-Driven Prospective Clinical Study Evaluating the Combination of an Antibiofilm Agent and Negative Pressure Wound Therapy

What is slough? Defining the proteomic and microbial composition of slough and its implications for wound healing

Challenges in Biofilm Identification in Diabetic Foot Infections: Review of Literature

Association of biofilm and microbial metrics with healing rate in older adults with chronic venous leg ulcers

A scoping review protocol to identify clinical signs, symptoms and biomarkers indicative of biofilm presence in chronic wounds

Development of In Vitro and Ex Vivo Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound Dressings

A proof‐of‐concept study of the removal of early and late phase biofilm from skin wound models using a liquid acoustic stream

Novel Diagnostic Technologies and Therapeutic Approaches Targeting Chronic Wound Biofilms and Microbiota

Bacterial protease activity as a biomarker to assess the risk of non-healing in chronic wounds: Results from a multicentre randomised controlled clinical trial

Reduction Of Biofilm In Chronic Wounds By Antibacterial Protease Combined With Silver Dressing

Impedance sensing device enables early detection of pressure ulcers in vivo

Early Application of Negative Pressure Wound Therapy to Acute Wounds Contaminated with Staphylococcus Aureus: an Effective Approach to Preventing Biofilm Formation.

Point‐of‐care fluorescence imaging reveals extent of bacterial load in diabetic foot ulcers

Identification of High-Risk Lower Extremity Wounds Using Point-of-Care Test for Bacterial Protease Activity; A Single-Centre, Single-Blinded, Prospective Study

Adaptive expression of biofilm regulators and adhesion factors of <i>Staphylococcus aureus</i> during acute wound infection under the treatment of negative pressure wound therapy <i>in vivo</i>

Advances in the Sensing and Treatment of Wound Biofilms